netFormulary
 Report : A-Z CDF items in Formulary 22/07/2019 08:43:12
[Back]
 
Section Status CDF Name
08.03.04.02 Formulary Cancer Drugs Fund Abiraterone Zytiga
08.02.03 Formulary Cancer Drugs Fund Atezolizumab Tecentriq
08.02.04 Formulary Cancer Drugs Fund Axicabtagene ciloleucel  YESCARTA
08.01.01 Formulary Cancer Drugs Fund Bendamustine 
08.01.05 Formulary Cancer Drugs Fund Bevacizumab 
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade
08.01.05 Formulary Cancer Drugs Fund Brentuximab vedotin Adcetris
08.01.05 Formulary Cancer Drugs Fund Cetuximab Erbitux
08.01.05 Formulary Cancer Drugs Fund Daratumumab Darzalex
08.01.05 Formulary Cancer Drugs Fund Dasatinib Sprycel
08.01.02 Formulary Cancer Drugs Fund Doxorubicin Hydrochloride Lipid formulation
08.01.05 Formulary Cancer Drugs Fund Ibrutinib Imbruvica
08.01.05 Restricted Use Cancer Drugs Fund Ixazomib 
08.02.03 Formulary Cancer Drugs Fund Nivolumab Opdivo
08.01.05 Formulary Cancer Drugs Fund Osimertinib 
08.01.05 Formulary Cancer Drugs Fund Panitumumab Vectibix
08.01.05 Formulary Cancer Drugs Fund Pembrolizumab Keytruda
08.01.03 Formulary Cancer Drugs Fund Pemetrexed Alimta
16.02 Formulary Cancer Drugs Fund Radium-223 Xofigo
01.01 Formulary Cancer Drugs Fund Remote Control Panasonic
08.01.05 Formulary Cancer Drugs Fund Sorafenib Nexavar
08.01.05 Formulary Cancer Drugs Fund Sunitinib Sutent
08.01.05 Formulary Cancer Drugs Fund Temsirolimus Torisel
08.01.05 Formulary Cancer Drugs Fund Tisagenlecleucel Kymriah
08.01.05 Formulary Cancer Drugs Fund Venetoclax Venclyxto
Birmingham, Sandwell, Solihull and environs APC Formulary